Eni said on Thursday it was providing Kazakhstan with the supply of medicine, worth about $1 million, needed to protect the health of the host community. The supply includes anticoagulants, corticosteroids and other items that have been shown to be effective in treating proven consequences according to international standards, especially with regard to the treatment, prevention of acute and delayed complications of COVID-19 .
Eni said that at this time it is crucial to keep the pandemic under control and to preserve the current capacity of the system by mitigating the post-COVID impact on patients and supporting the supply chain to meet demand. growing number of drugs.
“During the thirty years of Eni’s presence in Kazakhstan, we have responded to a wide range of social needs of the host community by implementing numerous social projects. In addition, over the past two years, Eni’s subsidiaries have supported the fight against COVID-19 both in the regions and in the capital of Nur-Sultan, providing equipment and PPE for a total amount of 700 000 USD, in addition to the current donation equal to approximately 1 million USD. These initiatives, reinforced by the delivery today of humanitarian aid specifically dedicated to medicines, are in line with Eni’s corporate social responsibility approach,” said Luciano Vasques, Head of Central Asia Region of Eni. .
This is a joint initiative of Eni and the Ministry of Health of the Republic of Kazakhstan to support the work of medical professionals aimed at controlling the consequences of the pandemic, the company said. The supplies will be distributed to medical organizations across the country by the single operator SK-Pharmacy based on priorities and needs.